Founders Fund

SafelyYou, Inc. is a technology company based in Berkeley, California, founded in 2015, that specializes in artificial intelligence software designed for managed Alzheimer's care. The company focuses on fall prevention by utilizing a camera system installed in patients' rooms to detect falls in real time and alert caregivers. Its AI-enabled technology analyzes patterns and signs that may indicate a potential fall, allowing for proactive intervention. SafelyYou's solutions aim to enhance the safety and well-being of individuals with Alzheimer's and other forms of dementia, facilitating improved medication adherence, behavioral monitoring, and overall care management in skilled nursing facilities and assisted living communities. By reducing the frequency and impact of falls, SafelyYou contributes to lowering hospitalization rates among this vulnerable population.

EnClear Therapies develops device-based therapies for treating neurodegenerative diseases by removing toxic proteins from cerebrospinal fluid. Its initial targets are Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP). Incorporated in 2018, the company is based in Newburyport, Massachusetts.

Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Mendaera is a medtech startup specializing in advanced healthcare technologies, focusing on robotics and diagnostic tools. Its platform integrates robotics, AI, real-time imaging, and connectivity to enable consistent medical interventions at scale, aiming to make high-quality care accessible to all patients.

Earable Neuroscience is a deep tech company focusing on building consumer wearables and solutions that unlock human potential through improved sleep and cognitive function. Earable was early-invested in by FoundersFund and Samsung Ventures. After 9 years of R&D at the University of Colorado and the University of Oxford, Earable invented FRENZ Brainband - a pioneering AI-powered sleep-aid wearable designed to track and stimulate brain activity in real time using science-backed personalized audio delivered via bone-conduction speakers.

Ultima Genomics is a biotechnology company established in 2016 and headquartered in Newark, California. It specializes in genome-scale sequencing technology, focusing on providing analytical services to various enterprises. By employing an open substrate, Ultima Genomics creates a vast, low-cost reaction surface that facilitates billions of reads without relying on expensive flow cells or complex fluidic systems. The company utilizes specialized sequencing hardware combined with machine learning techniques to ensure reproducible and accurate results. This innovative approach enables clients to obtain genomic reports at scale, enhancing the speed and efficiency of sequencing while significantly reducing costs. Ultima Genomics aims to harness the potential of genomic information to drive advancements in biology and improve human health.

Ostro is a health platform based in Miami, Florida, founded in 2019, that specializes in personalized engagement solutions for the life sciences sector. The company focuses on creating informative connections between medicine producers and consumers, enhancing healthcare experiences for both patients and healthcare professionals. Ostro's platform streamlines the patient journey, offering services such as virtual consultations, logistics, regulatory compliance, and integrated payment solutions. By personalizing healthcare journeys, Ostro aims to boost engagement and improve the overall health outcomes for millions of individuals while delivering value to life sciences brands.

Earable Neuroscience is a deep tech company focusing on building consumer wearables and solutions that unlock human potential through improved sleep and cognitive function. Earable was early-invested in by FoundersFund and Samsung Ventures. After 9 years of R&D at the University of Colorado and the University of Oxford, Earable invented FRENZ Brainband - a pioneering AI-powered sleep-aid wearable designed to track and stimulate brain activity in real time using science-backed personalized audio delivered via bone-conduction speakers.

HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.

SafelyYou, Inc. is a technology company based in Berkeley, California, founded in 2015, that specializes in artificial intelligence software designed for managed Alzheimer's care. The company focuses on fall prevention by utilizing a camera system installed in patients' rooms to detect falls in real time and alert caregivers. Its AI-enabled technology analyzes patterns and signs that may indicate a potential fall, allowing for proactive intervention. SafelyYou's solutions aim to enhance the safety and well-being of individuals with Alzheimer's and other forms of dementia, facilitating improved medication adherence, behavioral monitoring, and overall care management in skilled nursing facilities and assisted living communities. By reducing the frequency and impact of falls, SafelyYou contributes to lowering hospitalization rates among this vulnerable population.

Seed Health is a biotechnology company focused on therapeutics, consumer health innovations, and environmental solutions grounded in microbial sciences. It collaborates with academic researchers to advance discoveries in microbiology and develops health supplements that employ live biotherapeutics, combining probiotics and prebiotics to support digestive health, skin health, heart health, and micronutrient synthesis.

Seed Health is a biotechnology company focused on therapeutics, consumer health innovations, and environmental solutions grounded in microbial sciences. It collaborates with academic researchers to advance discoveries in microbiology and develops health supplements that employ live biotherapeutics, combining probiotics and prebiotics to support digestive health, skin health, heart health, and micronutrient synthesis.

Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.

Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

Ostro is a health platform based in Miami, Florida, founded in 2019, that specializes in personalized engagement solutions for the life sciences sector. The company focuses on creating informative connections between medicine producers and consumers, enhancing healthcare experiences for both patients and healthcare professionals. Ostro's platform streamlines the patient journey, offering services such as virtual consultations, logistics, regulatory compliance, and integrated payment solutions. By personalizing healthcare journeys, Ostro aims to boost engagement and improve the overall health outcomes for millions of individuals while delivering value to life sciences brands.

Sana Health, Inc. is a digital health company based in Lafayette, Colorado, with an additional office in Mill Valley, California. Founded in 2015, the company specializes in developing bio-therapeutic devices designed to promote relaxation and alleviate pain and tension. Its flagship product, Sana, is a non-addictive mask and headphone combination that utilizes audiovisual stimulation to enhance the balance between the left and right sides of the brain, facilitating a deep meditative state. This device employs coordinated pulses of light and sound to guide users into relaxation, mimicking the benefits of long-term meditation practices. Sana Health is also engaged in multiple clinical studies, focusing on applications for conditions such as fibromyalgia and neuropathic pain, as well as trials related to anxiety and PTSD. The company offers its products for sale online and provides a mobile application accessible via major app platforms.

Earable Neuroscience is a deep tech company focusing on building consumer wearables and solutions that unlock human potential through improved sleep and cognitive function. Earable was early-invested in by FoundersFund and Samsung Ventures. After 9 years of R&D at the University of Colorado and the University of Oxford, Earable invented FRENZ Brainband - a pioneering AI-powered sleep-aid wearable designed to track and stimulate brain activity in real time using science-backed personalized audio delivered via bone-conduction speakers.

Notable Labs, Inc. is a clinical-stage company that specializes in personalized lab testing services for cancer patients, particularly those with brain cancer. Founded in 2014 and based in Foster City, California, the company utilizes its proprietary Predictive Precision Medicines Platform to conduct drug combination experiments on patients' tumors. This platform allows Notable Labs to simulate cancer treatments and predict patient responses to specific therapies, enabling healthcare providers to prioritize combinations of FDA-approved treatments that can be prescribed without the need for clinical trials. By providing detailed reports to physicians, Notable Labs aims to enhance treatment efficacy and expedite therapeutic development for patients.

Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

Vium, Inc. is a biotechnology company founded in 2013 and headquartered in San Mateo, California. It specializes in developing digital biomarkers aimed at enhancing preclinical research and animal welfare. The company is fully accredited by AAALAC International and has received significant commendation for its commitment to the principles of humane animal research. Vium's digital platform, known as Digital Vivarium and Vium Cloud, utilizes advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively collect physiological metrics and behaviors. This innovative approach enables researchers and drug developers to gain improved insights into disease progression, thereby facilitating better decision-making regarding which compounds should progress to clinical trials. Its clientele includes a diverse array of biotechnology, pharmaceutical, and academic institutions, as well as novel therapeutic laboratories, all seeking more sensitive and accurate data for replicable studies.

Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

Neurotrack is a digital health company focused on the early detection and management of Alzheimer's disease and other dementias. It offers turnkey cognitive assessment platforms for providers to facilitate rapid, patient-guided screening and ongoing monitoring of cognitive function, usable in clinic or at home to fit diverse workflows. The platform employs eye-tracking technology and culturally-agnostic symbols to deliver rapid assessments with instant, objective scoring integrated with electronic health records, and supports remote and in-clinic administration, ongoing monitoring tools, and educational resources addressing modifiable risk factors. Neurotrack has published peer-reviewed research, holds patents on its proprietary technology, and has FDA Class II medical device status. Founded in 2012 and based in Redwood City, California.

Counsyl is a health technology company specializing in DNA screening services for individuals and families. The company focuses on providing critical information that can significantly influence health outcomes, enabling proactive measures and informed decision-making. With a strong commitment to accessibility, Counsyl has screened over 500,000 patients and collaborated with more than 6,000 healthcare professionals through its accredited clinical laboratory. It employs sophisticated technology and custom robotic automation to analyze blood and saliva samples with precision and efficiency. The platform not only aids in family planning through its Family Prep Screen but also encompasses informed pregnancy and cancer screening. Recognized for its innovative approach, Counsyl has received accolades such as the Wall Street Journal’s Innovation Award for Medicine and has been listed among Scientific American's "Top 10 World Changing Ideas." The company combines the expertise of scientists, engineers, and clinical professionals to enhance communication between patients and healthcare providers regarding medical results.

Nanotronics Imaging, Inc. is a high-tech company specializing in the manufacture of optical microscopes and advanced imaging solutions. Founded in 2007 and headquartered in Brooklyn, New York, with additional offices in Cuyahoga Falls, Ohio, and Hollister, California, the company develops a platform that integrates artificial intelligence, automation, and sophisticated imaging technology for industrial inspection. This platform automates the inspection of advanced technologies, including semiconductors, microchips, and medical devices. Key products include nSpec, an automated optical inspection system designed for analyzing transparent and semi-transparent wafers, and nSpec 3D, which provides surface topographies and quantitative roughness measurements. In addition to microscopy systems, Nanotronics Imaging offers hardware prototyping, production services, and a variety of related equipment, catering to industries such as aerospace, automotive, and materials science.

Sana Health, Inc. is a digital health company based in Lafayette, Colorado, with an additional office in Mill Valley, California. Founded in 2015, the company specializes in developing bio-therapeutic devices designed to promote relaxation and alleviate pain and tension. Its flagship product, Sana, is a non-addictive mask and headphone combination that utilizes audiovisual stimulation to enhance the balance between the left and right sides of the brain, facilitating a deep meditative state. This device employs coordinated pulses of light and sound to guide users into relaxation, mimicking the benefits of long-term meditation practices. Sana Health is also engaged in multiple clinical studies, focusing on applications for conditions such as fibromyalgia and neuropathic pain, as well as trials related to anxiety and PTSD. The company offers its products for sale online and provides a mobile application accessible via major app platforms.

Neurotrack is a digital health company focused on the early detection and management of Alzheimer's disease and other dementias. It offers turnkey cognitive assessment platforms for providers to facilitate rapid, patient-guided screening and ongoing monitoring of cognitive function, usable in clinic or at home to fit diverse workflows. The platform employs eye-tracking technology and culturally-agnostic symbols to deliver rapid assessments with instant, objective scoring integrated with electronic health records, and supports remote and in-clinic administration, ongoing monitoring tools, and educational resources addressing modifiable risk factors. Neurotrack has published peer-reviewed research, holds patents on its proprietary technology, and has FDA Class II medical device status. Founded in 2012 and based in Redwood City, California.

Stemcentrx is a biotechnology company focused on developing innovative therapies aimed at curing cancer and improving patient survival rates. Founded in 2008 by Brian Slingerland and Scott J. Dylla, the company is headquartered in South San Francisco, California. Stemcentrx specializes in creating disease-specific treatments that target cancer stem cells, the cells responsible for initiating and sustaining tumor growth. This approach allows healthcare providers to more effectively address the root causes of cancer, enhancing the potential for successful outcomes for patients. In 2016, Stemcentrx became a subsidiary of AbbVie, further expanding its resources and capabilities in the fight against cancer.

Tribogenics is a technology development company based in Los Angeles, California, focused on creating low-cost, portable X-ray solutions for various industries, including mining, industrial, military, and medical imaging. Utilizing triboluminescence technology originally developed at UCLA, the company has designed miniature X-ray devices that leverage a process akin to static electricity to generate X-rays. This innovative approach allows for convenient and accessible X-ray functions, enabling customers to conduct materials analysis and imaging in diverse settings without the constraints of traditional, larger X-ray systems.

Vium, Inc. is a biotechnology company founded in 2013 and headquartered in San Mateo, California. It specializes in developing digital biomarkers aimed at enhancing preclinical research and animal welfare. The company is fully accredited by AAALAC International and has received significant commendation for its commitment to the principles of humane animal research. Vium's digital platform, known as Digital Vivarium and Vium Cloud, utilizes advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively collect physiological metrics and behaviors. This innovative approach enables researchers and drug developers to gain improved insights into disease progression, thereby facilitating better decision-making regarding which compounds should progress to clinical trials. Its clientele includes a diverse array of biotechnology, pharmaceutical, and academic institutions, as well as novel therapeutic laboratories, all seeking more sensitive and accurate data for replicable studies.

Sols, Inc., established in 2013 and headquartered in New York, specializes in customized orthotic solutions for foot support. The company offers two primary products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct-to-consumer custom insoles. Sols' innovative approach combines software, mobile applications, and advanced technologies like computer vision and machine learning to create tailored footwear solutions that address alignment issues, promote proper gait, and relieve plantar fascia pressure. The company serves customers in the United States and is a subsidiary of Aetrex Worldwide, Inc.

Vium, Inc. is a biotechnology company founded in 2013 and headquartered in San Mateo, California. It specializes in developing digital biomarkers aimed at enhancing preclinical research and animal welfare. The company is fully accredited by AAALAC International and has received significant commendation for its commitment to the principles of humane animal research. Vium's digital platform, known as Digital Vivarium and Vium Cloud, utilizes advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively collect physiological metrics and behaviors. This innovative approach enables researchers and drug developers to gain improved insights into disease progression, thereby facilitating better decision-making regarding which compounds should progress to clinical trials. Its clientele includes a diverse array of biotechnology, pharmaceutical, and academic institutions, as well as novel therapeutic laboratories, all seeking more sensitive and accurate data for replicable studies.

Stemcentrx is a biotechnology company focused on developing innovative therapies aimed at curing cancer and improving patient survival rates. Founded in 2008 by Brian Slingerland and Scott J. Dylla, the company is headquartered in South San Francisco, California. Stemcentrx specializes in creating disease-specific treatments that target cancer stem cells, the cells responsible for initiating and sustaining tumor growth. This approach allows healthcare providers to more effectively address the root causes of cancer, enhancing the potential for successful outcomes for patients. In 2016, Stemcentrx became a subsidiary of AbbVie, further expanding its resources and capabilities in the fight against cancer.

Sols, Inc., established in 2013 and headquartered in New York, specializes in customized orthotic solutions for foot support. The company offers two primary products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct-to-consumer custom insoles. Sols' innovative approach combines software, mobile applications, and advanced technologies like computer vision and machine learning to create tailored footwear solutions that address alignment issues, promote proper gait, and relieve plantar fascia pressure. The company serves customers in the United States and is a subsidiary of Aetrex Worldwide, Inc.

Epinomics Inc. specializes in advancing personalized medicine by leveraging big data analytics and proprietary epigenomics technology. Founded in 2013 and located in Menlo Park, California, the company focuses on decoding the human genome to enhance drug development and clinical applications. By utilizing innovative DNA sequencing technology, Epinomics aims to improve existing methodologies in the field, facilitating deeper scientific research and the development of clinical applications. As of March 31, 2018, Epinomics operates as a subsidiary of 10X Genomics, Inc., furthering its mission to revolutionize healthcare through precision medicine.

Nanotronics Imaging, Inc. is a high-tech company specializing in the manufacture of optical microscopes and advanced imaging solutions. Founded in 2007 and headquartered in Brooklyn, New York, with additional offices in Cuyahoga Falls, Ohio, and Hollister, California, the company develops a platform that integrates artificial intelligence, automation, and sophisticated imaging technology for industrial inspection. This platform automates the inspection of advanced technologies, including semiconductors, microchips, and medical devices. Key products include nSpec, an automated optical inspection system designed for analyzing transparent and semi-transparent wafers, and nSpec 3D, which provides surface topographies and quantitative roughness measurements. In addition to microscopy systems, Nanotronics Imaging offers hardware prototyping, production services, and a variety of related equipment, catering to industries such as aerospace, automotive, and materials science.

Neurotrack is a digital health company focused on the early detection and management of Alzheimer's disease and other dementias. It offers turnkey cognitive assessment platforms for providers to facilitate rapid, patient-guided screening and ongoing monitoring of cognitive function, usable in clinic or at home to fit diverse workflows. The platform employs eye-tracking technology and culturally-agnostic symbols to deliver rapid assessments with instant, objective scoring integrated with electronic health records, and supports remote and in-clinic administration, ongoing monitoring tools, and educational resources addressing modifiable risk factors. Neurotrack has published peer-reviewed research, holds patents on its proprietary technology, and has FDA Class II medical device status. Founded in 2012 and based in Redwood City, California.

Tribogenics is a technology development company based in Los Angeles, California, focused on creating low-cost, portable X-ray solutions for various industries, including mining, industrial, military, and medical imaging. Utilizing triboluminescence technology originally developed at UCLA, the company has designed miniature X-ray devices that leverage a process akin to static electricity to generate X-rays. This innovative approach allows for convenient and accessible X-ray functions, enabling customers to conduct materials analysis and imaging in diverse settings without the constraints of traditional, larger X-ray systems.

Stemcentrx is a biotechnology company focused on developing innovative therapies aimed at curing cancer and improving patient survival rates. Founded in 2008 by Brian Slingerland and Scott J. Dylla, the company is headquartered in South San Francisco, California. Stemcentrx specializes in creating disease-specific treatments that target cancer stem cells, the cells responsible for initiating and sustaining tumor growth. This approach allows healthcare providers to more effectively address the root causes of cancer, enhancing the potential for successful outcomes for patients. In 2016, Stemcentrx became a subsidiary of AbbVie, further expanding its resources and capabilities in the fight against cancer.

Med-Tech Solutions, Inc. is a Canadian company based in Vancouver, specializing in the design, development, and marketing of specialty medical devices focused on women's health care. Founded in 2004, the company holds a license to manufacture, market, and distribute a medical pessary device known as Gynecone, which is utilized in the treatment of female urinary incontinence. In addition to Gynecone, Med-Tech Solutions designs various pessary devices specifically for addressing prolapsed tissue. In 2007, the company underwent a reverse merger, becoming part of The Four Rivers BioEnergy Company Inc.

Counsyl is a health technology company specializing in DNA screening services for individuals and families. The company focuses on providing critical information that can significantly influence health outcomes, enabling proactive measures and informed decision-making. With a strong commitment to accessibility, Counsyl has screened over 500,000 patients and collaborated with more than 6,000 healthcare professionals through its accredited clinical laboratory. It employs sophisticated technology and custom robotic automation to analyze blood and saliva samples with precision and efficiency. The platform not only aids in family planning through its Family Prep Screen but also encompasses informed pregnancy and cancer screening. Recognized for its innovative approach, Counsyl has received accolades such as the Wall Street Journal’s Innovation Award for Medicine and has been listed among Scientific American's "Top 10 World Changing Ideas." The company combines the expertise of scientists, engineers, and clinical professionals to enhance communication between patients and healthcare providers regarding medical results.

100Plus is a rapidly growing remote patient monitoring platform designed to enhance the management of chronic patients, particularly among the elderly. The company provides an integrated solution that includes patient outreach, device setup, patient engagement, and automatic billing, all without requiring smartphones, apps, Bluetooth, or WiFi. This simplifies the process for both patients and healthcare providers. By delivering fully configured medical devices at no cost to Medicare patients or practices, 100Plus facilitates continuous monitoring of high-risk seniors, enabling healthcare professionals to proactively engage with patients. This approach aims to reduce the need for expensive episodic care and improve overall quality of life for patients.

Ingenic is an online learning platform designed to enhance educators' ability to provide personalized feedback and engaging course activities. It facilitates efficient management of virtual lessons and course materials, improving the education feedback loop.

HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.

HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.